UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 30, 2015
The Spectranetics Corporation
(Exact name of registrant as specified in its charter)
|
| | | | | | |
| | Delaware | | 000-19711 | | 84-0997049 | |
| | (State or other jurisdiction | | (Commission | | (IRS Employer | |
| | of incorporation) | | File Number) | | Identification No.) | |
|
|
| 9965 Federal Drive |
| Colorado Springs, Colorado 80921 |
| (Address of principal executive offices) (Zip Code) |
Registrant’s telephone number, including area code: (719) 633-8333
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On September 30, 2015, The Spectranetics Corporation (the “Company”) issued a press release announcing that a jury in the U.S. District Court for the Northern District of California has found against its wholly-owned subsidiary, AngioScore Inc., the plaintiff in a lawsuit seeking damages and other relief for patent infringement against defendants Eitan Konstantino, TriReme Medical, LLC, Quattro Vascular Pte Ltd. and QT Vascular Ltd. related to defendants’ Chocolate PTA balloon catheter. A copy of the press release is furnished as Exhibit 99.1 of this report.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
| |
| Exhibit No. | Description |
| | |
| 99.1 | The Spectranetics Corporation Press Release dated September 30, 2015 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| | | |
| | | THE SPECTRANETICS CORPORATION |
| | | (registrant) |
| | | |
| | | |
| Date: | September 30, 2015 | By: | /s/ Jeffrey A. Sherman |
| | | | Jeffrey A. Sherman |
| | | | Vice President, Deputy General Counsel and Corporate Secretary |
| | | | |
EXHIBIT INDEX
|
| |
| Exhibit No. | Description |
| | |
| 99.1 | The Spectranetics Corporation Press Release dated September 30, 2015 |
